Trial Profile

An Open-Label, One-Arm, Multi-Site Trial of Precision Diagnosis Directing Histone Deacetylase Inhibitor Chidamide Target Total Therapy for Adult Early T-cell Progenitor Acute Lymphoblastic Leukemia/Lymphoma

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 10 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tucidinostat (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Idarubicin; Mercaptopurine; Methotrexate; Pegaspargase; Vincristine
Indications Precursor T-cell lymphoblastic leukaemia-lymphoma
Focus Therapeutic Use

04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
20 Jun 2018 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com